Liao Shiyao, Gao Xing, Zhou Kai, Kang Yao, Ji Lichen, Zhong Xugang, Lv Jun
Center for Plastic & Reconstructive Surgery, Department of Orthopedics, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou, Zhejiang, 310014, China.
Department of Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215000, China.
Heliyon. 2024 Dec 19;11(1):e41358. doi: 10.1016/j.heliyon.2024.e41358. eCollection 2025 Jan 15.
The present study aims to explore the metastasis-related signatures in connection with tumor microenvironment (TME), revealing new molecular targets promising in improving osteosarcoma (OS) patients' outcomes.
The high-throughput sequencing data was downloaded from the TARGET database and performed the ESTIMATE algorithm. Metastasis-related information was obtained from the GSE21257 dataset. Differentially expressed genes (DEGs) associated with the stromal and immune cell infiltration patterns were identified. DEGs with similar biological functions were grouped into the same module by Gene Ontology (GO) analysis and MCODE analysis. Prognostic DEGs were selected in two datasets through survival analysis. Weighted gene co-expression network analysis (WGCNA) was performed to find metastasis-related modules and genes. RT-PCR was utilized to evaluate the expression of the key prognostic DEGs associated with metastasis in OS patients.
The median scores of the stromal and immune groups of OS samples were 58 and -416, and a total of 200 overlapping DEGs were identified. These DEGs basically played fundamental roles in immune response relevant GO terms and were clustered into 9 different modules. Among them, 24 metastasis-related DEGs were selected from the GSE21257 dataset which contains the stromal and immune cell infiltration patterns. Finally, IRF8, HLA-DMA, and HLA-DMB were proved to exhibit significant higher expression levels in cancerous tissues than in para-cancerous tissues for OS patients.
We identified three principal genes as promising signatures for predicting the survival the prognosis of OS patients. Exploration of metastasis-related signatures in TME may be valuable for enhancing treatment strategies for OS.
本研究旨在探索与肿瘤微环境(TME)相关的转移特征,揭示有望改善骨肉瘤(OS)患者预后的新分子靶点。
从TARGET数据库下载高通量测序数据并执行ESTIMATE算法。从GSE21257数据集中获取转移相关信息。鉴定与基质和免疫细胞浸润模式相关的差异表达基因(DEGs)。通过基因本体(GO)分析和MCODE分析将具有相似生物学功能的DEGs分组到同一模块中。通过生存分析在两个数据集中选择预后DEGs。进行加权基因共表达网络分析(WGCNA)以找到转移相关模块和基因。利用RT-PCR评估骨肉瘤患者中与转移相关的关键预后DEGs的表达。
骨肉瘤样本的基质组和免疫组的中位数分数分别为58和-416,共鉴定出200个重叠的DEGs。这些DEGs在与免疫反应相关的GO术语中基本发挥着重要作用,并被聚类为9个不同的模块。其中,从包含基质和免疫细胞浸润模式的GSE21257数据集中选择了24个与转移相关的DEGs。最后,对于骨肉瘤患者,IRF8、HLA-DMA和HLA-DMB在癌组织中的表达水平明显高于癌旁组织。
我们确定了三个主要基因作为预测骨肉瘤患者生存和预后的有前景的特征。探索肿瘤微环境中与转移相关的特征可能对加强骨肉瘤的治疗策略具有重要价值。